Synapse

← Rolf Wachter

Papers by Rolf Wachter

Page 1 · newest first

  1. Stroke-CORE: master study protocol of the national cohort of the specialty network stroke within the network university medicine in GermanyNeurological Research and Practice · 2026
  2. Atrial fibrillation in stroke patients: facts, numbers and current challengesNeurological Research and Practice · 2026
  3. The current state of care delivery in cardiac rhythm monitoring after ischemic strokeDeutsches Ärzteblatt international · 2026
  4. PVI-SHAM-AF: what does this trial tell us about catheter ablation and symptoms in patients with atrial fibrillation?Clinical Research in Cardiology · 2026
  5. Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trialThe Lancet · 2026
  6. Sex Differences in Exercise Training Response Among HFpEF Patients: Pooled Analysis of OptimEx-Clin and Ex-DHF-TrialsEuropean Journal of Heart Failure · 2026
  7. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fractionEuropean Heart Journal · 2011
  8. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology · 2011
  9. Intraoperative text messaging to reduce parental stress during outpatient pediatric surgery: a randomized trialPediatric Research · 2026
  10. Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trialEuropean Heart Journal · 2025
  11. Evaluation of predictors indicating paroxysmal atrial fibrillation in patients with acute ischemic strokes: the Find-AFRANDOMISED trialNeurological Research and Practice · 2026
  12. Comparative immune profiling in HFpEF: cross-species insights into inflammation and mitochondrial dysfunctionEuropean Heart Journal · 2025
  13. Risk of atrial fibrillation in patients with ischemic stroke and signs of left atrial cardiomyopathyEuropean Heart Journal · 2025
  14. Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fractionESC Heart Failure · 2026
  15. Diagnosing HFpEF in Patients With Unexplained Dyspnea by Using Invasive Left Ventricular Pressure-Volume LoopsJournal of Cardiac Failure · 2025
  16. Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imagingEuropean Heart Journal · 2025
  17. Effects of exercise training on motivation in patients with heart failure with preserved ejection fraction: Results from the randomized controlled Ex-DHF trialJournal of Psychosomatic Research · 2025
  18. Circulating Immune Cell Signature Analysis in HFpEF Across SpeciesCirculation Research · 2025
  19. Rationale and Design of the Randomized ‘Early Ventricular Assist Device’—Trial (VAD-DZHK3)ESC Heart Failure · 2025
  20. Cardiac Magnetic Resonance Imaging vs Coronary Angiography as Primary Strategy in Newly Diagnosed Heart FailureJACC Heart Failure · 2025
  21. Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trialNeurological Research and Practice · 2025
  22. Pulmonary vein isolation versus SHAM-pulmonary vein isolation for symptomatic relief in patients with atrial fibrillation—Design and rationale of the PVI-SHAM-AF trialAmerican Heart Journal · 2025
  23. Efficacy of Team-Based Collaborative Care for Distressed Patients in Secondary Prevention of Chronic Coronary Heart Disease: Results from the Multicenter, Randomized Controlled TEACH TrialPsychotherapy and Psychosomatics · 2025
  24. Association between comorbidities and the effects of exercise training among patients with heart failure with preserved ejection fractionEuropean Journal of Preventive Cardiology · 2025
  25. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fractionCardiovascular Diabetology · 2025
  26. Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm AssociationEP Europace · 2025
  27. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialThe Lancet · 2025
  28. Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trialNature Medicine · 2025
  29. Right Ventricular Systolic Dysfunction Predicts Recovery of Left Ventricular Systolic Function and Reduced Quality of Life in Patients With Arrhythmia‐Induced CardiomyopathyClinical Cardiology · 2025
  30. Identification and characteristics of distressed patients with coronary heart disease and insufficiently controlled medical risk factors: baseline findings and sex differences from the multicenter TEACH trialFrontiers in Psychiatry · 2025
  31. Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trialNature Medicine · 2025
  32. A simple blinding index for randomized controlled trialsContemporary Clinical Trials Communications · 2024
  33. Detection of atrial fibrillation after stroke due to large or small vessel disease: Systematic review and meta-analysisInternational Journal of Stroke · 2024
  34. Comparison of vessel-Fractional Flow Reserve (vFFR) and Quantitative Flow Ratio (QFR) using instantaneous wave-Free Ratio (iFR) or Resting Full-cycle Ratio (RFR) as referenceEuropean Heart Journal · 2024
  35. Diagnosing heart failure with preserved ejection fraction in patients with unexplained dyspnoea using left ventricular pressure-volume loops at rest and on exertionEuropean Heart Journal · 2024
  36. Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF TrialCirculation · 2024
  37. Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic StrokeJournal of the American Heart Association · 2024
  38. Deep vein thrombosis in patients with stroke or transient ischemic attack presenting with patent foramen ovale: a retrospective observational studyBMC Neurology · 2024
  39. Effects of baroreflex activation therapy on cardiac function and morphologyESC Heart Failure · 2024
  40. Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort studyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2024
  41. Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 StudyCirculation · 2024
  42. Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failureGlobal Cardiology · 2024
  43. Implementation of Guideline-Directed Medical Therapy for Heart FailureEuropean Journal of Heart Failure · 2024
  44. Long-term effects of exercise training in patients with heart failure with preserved ejection fraction - a follow-up study of two randomised controlled trialsEuropean Journal of Preventive Cardiology · 2024
  45. Pivotal Trials Testing the Efficacy of Novel Anticoagulants for Preventing Emerging Cardioembolic Risk EntitiesJournal of the American Heart Association · 2024
  46. Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHFESC Heart Failure · 2024
  47. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatmentClinical Research in Cardiology · 2024
  48. Age-Dependent Detection of Atrial Fibrillation with Implantable Cardiac Monitors in Patients with Cryptogenic StrokeTH Open · 2024
  49. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trialEuropean Journal of General Practice · 2024
  50. Clinical Characterization of Arrhythmia-Induced Cardiomyopathy in Patients With Tachyarrhythmia and Idiopathic Heart FailureJACC. Clinical electrophysiology · 2024